Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amaury Pajon"'
Autor:
Dominique Bernard-Gallon, Françoise Degoul, Yves-Jean Bignon, Florence Mishellany, Marine Daures, Lucas Dubois, Sophie Besse, Amaury Pajon, Khaldoun Rifaï, Frédérique Penault-Llorca, Gaëlle Judes, Mouhamed Idrissou
Publikováno v:
Epigenomics
Epigenomics, Future Medicine, 2018, 10 (11), pp.1415-1430. ⟨10.2217/epi-2018-0004⟩
Epigenomics, Future Medicine, 2018, 10 (11), pp.1415-1430. ⟨10.2217/epi-2018-0004⟩
Aim: The acetyltransferase TIP60 is reported to be downregulated in several cancers, in particular breast cancer, but the molecular mechanisms resulting from its alteration are still unclear. Materials & methods: In breast tumors, H3K4ac enrichment a
Autor:
Gaëlle Judes, Yves-Jean Bignon, Dominique Bernard-Gallon, Marjolaine Ngollo, Seher Karsli-Ceppioglu, Aslihan Dagdemir, Amaury Pajon, Frédérique Penault-Llorca
Publikováno v:
Epigenomics. 6:651-664
Epigenetic alterations are heritable changes in gene expression that occur without causing any change in DNA sequence. They are important key factors for cancer development and prognosis. Breast cancer is induced by the accumulation of altered gene r
Autor:
Amaury Pajon, Frédérique Penault-Llorca, Marjolaine Ngollo, Aslihan Dagdemir, Dominique Bernard-Gallon, Laurent Guy, Gaëlle Judes, Jean-Paul Boiteux, Yves-Jean Bignon, Seher Karsli-Ceppioglu
Publikováno v:
Epigenomics. 6:415-426
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths in men in France. Apart from the genetic alterations in prostate cancer, epigenetics modifications are involved in the development and progression of this
Autor:
Dominique Bernard-Gallon, Gaëlle Judes, Mawussi Adjakly, Marjolaine Ngollo, Aslihan Dagdemir, Amaury Pajon, Laurent Guy, Frédérique Penault-Llorca, Yves-Jean Bignon, Jean-Paul Boiteux, Seher Karsli-Ceppioglu
Publikováno v:
Annales d'endocrinologie. 76(1)
With 13 million new cases worldwide every year, prostate cancer is as a very real public health concern. Prostate cancer is common in over-50s men and the sixth-leading cause of cancer-related death in men worldwide. Like all cancers, prostate cancer